DMAC Covered Call Strategy

DMAC (DiaMedica Therapeutics Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

DiaMedica Therapeutics Inc. operates as a clinical-stage biopharmaceutical entity dedicated to advancing therapeutic solutions for neurological and renal disorders. Its primary drug candidate, DM199, a recombinant human tissue kallikrein-1 protein, is currently undergoing a Phase 2 REDUX trial to assess its efficacy in treating moderate to severe chronic kidney disease linked to Type 1 or Type 2 diabetes. Furthermore, DM199 is being evaluated in Phase 2/3 REMEDY2 trials for acute ischemic stroke patients. In addition to DM199, the company is also developing DM300, which is in its pre-clinical stage for the treatment of various inflammatory conditions. Founded in 2000 and headquartered in Minneapolis, Minnesota, the company was previously known as DiaMedica Inc. before adopting its current name, DiaMedica Therapeutics Inc., in December 2016.

DMAC (DiaMedica Therapeutics Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $352.9M, a beta of 1.00 versus the broader market, a 52-week range of 3.475-10.4195, average daily share volume of 192K, a public-listing history dating back to 2012, approximately 27 full-time employees. These structural characteristics shape how DMAC stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.00 places DMAC roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a covered call on DMAC?

A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.

Current DMAC snapshot

As of June 30, 2026, spot at $7.08, ATM IV 216.10%, IV rank 46.96%, expected move 61.95%. The covered call on DMAC below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this covered call structure on DMAC specifically: DMAC IV at 216.10% is mid-range versus its 1-year history, so the credit collected on a DMAC covered call sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 61.95% (roughly $4.39 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated DMAC expiries trade a higher absolute premium for lower per-day decay. Position sizing on DMAC should anchor to the underlying notional of $7.08 per share and to the trader's directional view on DMAC stock.

DMAC covered call setup

The DMAC covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With DMAC near $7.08, the first option leg uses a $7.43 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed DMAC chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 DMAC shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 100 sharesStock$7.08long
Sell 1Call$7.43N/A

DMAC covered call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.

DMAC covered call payoff curve

Modeled P&L at expiration across a range of underlying prices for the covered call on DMAC. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use covered call on DMAC

Covered calls on DMAC are an income strategy run on existing DMAC stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.

DMAC thesis for this covered call

The market-implied 1-standard-deviation range for DMAC extends from approximately $2.69 on the downside to $11.47 on the upside. A DMAC covered call collects premium on an existing long DMAC position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether DMAC will breach that level within the expiration window. Current DMAC IV rank near 46.96% is mid-range against its 1-year distribution, so the IV signal is neutral; the covered call thesis on DMAC should anchor more to the directional view and the expected-move geometry. As a Healthcare name, DMAC options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to DMAC-specific events.

DMAC covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. DMAC positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move DMAC alongside the broader basket even when DMAC-specific fundamentals are unchanged. Short-premium structures like a covered call on DMAC carry tail risk when realized volatility exceeds the implied move; review historical DMAC earnings reactions and macro stress periods before sizing. Always rebuild the position from current DMAC chain quotes before placing a trade.

Frequently asked questions

What is a covered call on DMAC?
A covered call on DMAC is the covered call strategy applied to DMAC (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With DMAC stock trading near $7.08, the strikes shown on this page are snapped to the nearest listed DMAC chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are DMAC covered call max profit and max loss calculated?
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the DMAC covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 216.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a DMAC covered call?
The breakeven for the DMAC covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current DMAC market-implied 1-standard-deviation expected move is approximately 61.95%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a covered call on DMAC?
Covered calls on DMAC are an income strategy run on existing DMAC stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
How does current DMAC implied volatility affect this covered call?
DMAC ATM IV is at 216.10% with IV rank near 46.96%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related DMAC analysis